Recognition of CLSI's 34th Edition M100 Performance Standards for Antimicrobial Susceptibility Testing

If your email program has trouble displaying this email, view as a webpage.

Notice of Updates – FDA Recognized Antimicrobial Susceptibility Test Interpretive Criteria

FDA Updates

As of May 28, 2024 with certain exceptions, FDA recognizes the standard published in:

Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. 34th ed. CLSI supplement M100. Clinical and Laboratory Standards Institute; 2024.

** If you did not subscribe to the FDA Recognized Antimicrobial STIC Breakpoints subscription you may unsubscribe from this list by clicking on the "Manage Preferences or Unsubscribe from this List" link below.